At the beginning of Trientine therapy, there is a chance that clinical symptoms will get worse, according to the FDA. Some Wilson's disease patients experienced a neurological decline during the first stage of treatment, including tremors, dystonia, and dysarthria. Healthcare professionals should exercise caution when starting Trientine therapy and keep an eye out for any symptoms of symptom worsening or negative side effects. Prompt assessment and management are essential for effectively resolving these potential issues and ensuring the safe and optimal use of the medication in patients with Wilson's condition. This drug is a commonly accessible medication that is simple to buy Trientine in Brazil and incorporate into treatment plans. To know more, visit https://indiangenericmedicines.com/misc/trientine/.